Moutih Rafei
Company: Defence Therapeutics
Job title: Chief Scientific Officer
Seminars:
AccuTOX-Reprogrammed Mesenchymal Stromal Cells (ARM-X): An Alternative Cellular Vector for Cancer Immunotherapy 4:00 pm
Reprogramming mesenchymal stromal cells in individualized cancer vaccines to present antigens to the immune system Employing a fast design and manufacture method of personalized cancer vaccines that is applicable to many indications for effective tumor control Unearthing the use of cancer vaccines with checkpoint inhibitors for hard-to-treat cancersRead more
day: Conference Day One